Cargando…
San-Huang-Chai-Zhu Formula Ameliorates Liver Injury in Intrahepatic Cholestasis through Suppressing SIRT1/PGC-1α-Regulated Mitochondrial Oxidative Stress
BACKGROUND: Chinese herbal formulae possess promising applications in treating intrahepatic cholestasis. OBJECTIVE: Our study aims to explore the protective effect of the San-Huang-Chai-Zhu formula (SHCZF) on liver injury in intrahepatic cholestasis (IC) and investigate the underlying mechanism rela...
Autores principales: | Liu, Binbin, Zhang, Jie, Shao, Lu, Yao, Jiaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286970/ https://www.ncbi.nlm.nih.gov/pubmed/35845569 http://dx.doi.org/10.1155/2022/7832540 |
Ejemplares similares
-
Network pharmacology analysis and molecular docking to unveil the potential mechanisms of San-Huang-Chai-Zhu formula treating cholestasis
por: Liu, Binbin, et al.
Publicado: (2022) -
Predicting Target Genes of San-Huang-Chai-Zhu Formula in Treating ANIT-Induced Acute Intrahepatic Cholestasis Rat Model via Bioinformatics Analysis Combined with Experimental Validation
por: Yao, Jiaming, et al.
Publicado: (2021) -
The IDI1/SREBP2 axis drives intrahepatic cholestasis and is a treatment target of San-Huang-Cai-Zhu formula identified by sequencing and experiments
por: Yan, Junbin, et al.
Publicado: (2023) -
First person – Jun-yi Zhu and Xiaohu Huang
Publicado: (2021) -
Da-Chai-Hu-Tang Protects From Acute Intrahepatic Cholestasis by Inhibiting Hepatic Inflammation and Bile Accumulation via Activation of PPARα
por: Xu, Shihao, et al.
Publicado: (2022)